News & Analysis on Clinical Trial Services & Contract Research And Development
A new drug target, which blocks the reproduction of cancerous cells without the side effects commonly associated with existing cancer drugs, has been discovered by scientists who believe this target is linked to other diseases including diabetes and...
In a defiant gesture to animal activists, Britain's pharmaceutical companies have joined forces to launch a £4m research fund to finance animal experiments in universities.
UK biotechnology company CellFactors has entered administration following its failure to raise additional funds to further develop its product Skeletex, a biological matrix derived from human cells that induces new vascularised bone growth.
Locus Pharmaceuticals have acquired the drug discovery company Protein Mechanics, which brings together novel technologies that broaden the scope of drug targets and further strengthens its position as a leading company in computational drug design.